Volume 10 Supplement 1
2076 Comparison between black and bright blood T2* measurements in thalassemia
© He et al; licensee BioMed Central Ltd. 2008
Published: 22 October 2008
To assess the reproducibility between the developed breath-hold black blood and bright blood T2* sequences for myocardial iron measurement.
Early iron detection using myocardial T2* values derived from Cardiovascular Magnetic Resonance (CMR) has been reported in significant sized populations [1, 2], and validated [3–6]. Nevertheless, the current bright blood technique does not provide high contrast between the signal from the blood pool and that from the myocardium, and some images appear to have blood signal artifacts and partial volume effects affecting the myocardium that would most likely reduce the accuracy of the T2* measurement. The recent development of a T2* sequence with black blood preparation provides more clearly defined endocardial borders and reduces artifacts from blood which affects the myocardial signal measurement and this has been shown to have improved reproducibility . Although it was demonstrated on 10 patients  that the T2* measurements from both sequences were comparable, it is of clinical interest to compare them on a large population of patients.
112 thalassemia patients were studied on a 1.5 T MRI scanner (Siemens Sonata) using a cardiac phased array coil and with ECG gating. The study was approved by the local ethics committee and all patients gave informed consent.
All patients were scanned using the bright blood  and the black blood  T2* sequence subsequently, each within a breath-hold. A single mid-ventricular short axis slice was imaged with T2* measured in the left ventricular septum. The black blood data was analysed by the first author using the mono-exponential model. The bright blood data was analysed independently by another experienced observer using the truncation model [8, 9]. The nonlinear curve fitting algorithm was employed for all the data analysis (CMRtools, Imperial College London).
This study demonstrated the good reproducibility between the breath-hold black blood and the validated bright blood T2* techniques on a large population of thalassemia patients. Also, no bias between these two measurements was found. It indicates that the black blood T2* measurement is clinically relevant. Hence, the black blood T2* measurement is recommended because of its improved reproducibility. These findings further suggest that the T2* technique is reliable for myocardial iron quantification in patients with iron overload conditions such as thalassemia.
This work was supported by NIH Grant: R01 DK66084-01.
- Anderson LJ, Holden S, Davies B: Eur Heart J. 2001, 22: 2171-2179. 10.1053/euhj.2001.2822.View ArticlePubMedGoogle Scholar
- Tanner MA, Galanello R, Dessi C: 2006, 8: 543-547.Google Scholar
- Westwood M, Anderson LJ, Firmin DN: J Magn Reson Imaging. 2003, 18: 33-39. 10.1002/jmri.10332.View ArticlePubMedGoogle Scholar
- Westwood MA, Anderson LJ, Firmin DN: J Magn Reson Imaging. 2003, 18: 616-620. 10.1002/jmri.10396.View ArticlePubMedGoogle Scholar
- Wood JC, Tyszka JM, Carson S: Blood. 2004, 103: 1934-1936. 10.1182/blood-2003-06-1919.View ArticlePubMedGoogle Scholar
- Wood JC, Otto-Duessel M, Aguilar M: Circulation. 2005, 112: 535-543. 10.1161/CIRCULATIONAHA.104.504415.PubMed CentralView ArticlePubMedGoogle Scholar
- He T, Gatehouse PD, Kirk P: 2007, 25: 1205-1209.Google Scholar
- He T, Gatehouse PD, Keegan J: ISMRM 15th Scientific Meeting. 2006, May , Berlin, GermanyGoogle Scholar
- He T, Smith GC, Kirk P: ISMRM 15th Scientific Meeting. 2006, May , Berlin, GermanyGoogle Scholar
This article is published under license to BioMed Central Ltd.